EP1311280A4 - Cell internalized peptide-drug conjugates - Google Patents

Cell internalized peptide-drug conjugates

Info

Publication number
EP1311280A4
EP1311280A4 EP01956077A EP01956077A EP1311280A4 EP 1311280 A4 EP1311280 A4 EP 1311280A4 EP 01956077 A EP01956077 A EP 01956077A EP 01956077 A EP01956077 A EP 01956077A EP 1311280 A4 EP1311280 A4 EP 1311280A4
Authority
EP
European Patent Office
Prior art keywords
drug conjugates
internalized peptide
cell internalized
cell
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01956077A
Other languages
German (de)
French (fr)
Other versions
EP1311280A2 (en
Inventor
Teruna J Siahaan
Helena Yusuf-Makagiansar
Meagan Anderson
Rong Christine Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Publication of EP1311280A2 publication Critical patent/EP1311280A2/en
Publication of EP1311280A4 publication Critical patent/EP1311280A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
EP01956077A 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates Withdrawn EP1311280A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US629719 1996-04-09
US62971900A 2000-08-01 2000-08-01
PCT/US2001/024088 WO2002009649A2 (en) 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates

Publications (2)

Publication Number Publication Date
EP1311280A2 EP1311280A2 (en) 2003-05-21
EP1311280A4 true EP1311280A4 (en) 2005-02-23

Family

ID=24524196

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01956077A Withdrawn EP1311280A4 (en) 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates

Country Status (5)

Country Link
EP (1) EP1311280A4 (en)
JP (1) JP2004505029A (en)
AU (1) AU2001278113A1 (en)
CA (1) CA2417885A1 (en)
WO (1) WO2002009649A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101189339A (en) * 2005-03-22 2008-05-28 美得思达健康有限公司 Delivery systems and methods for diagnosing and treating cardiovascular diseases
CA2825641C (en) * 2011-02-02 2016-10-11 Medipost Co., Ltd. Use of icam-1 for prevention or treatment of neurological diseases
WO2018031947A1 (en) * 2016-08-12 2018-02-15 Immunowork, Llc Diagnosis, prevention, and/or treatment of autoimmune diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028170A1 (en) * 1994-04-19 1995-10-26 The University Of Kansas Icam-1/lfa-1 short-chain peptides and method of using same
WO1997041149A1 (en) * 1996-04-26 1997-11-06 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183805A (en) * 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028170A1 (en) * 1994-04-19 1995-10-26 The University Of Kansas Icam-1/lfa-1 short-chain peptides and method of using same
WO1997041149A1 (en) * 1996-04-26 1997-11-06 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDERSON MEAGAN E ET AL: "Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: Designing peptide and small molecule inhibitors.", PEPTIDES (NEW YORK), vol. 24, no. 3, March 2003 (2003-03-01), pages 487 - 501, XP002290396, ISSN: 0196-9781 *
See also references of WO0209649A3 *
SIAHAAN T J ET AL: "UTILIZATION OF CELL-ADHESION PEPTIDES TO IMPROVE DRUG DELIVERY", PEPTIDES FOR THE NEW MILLENNIUM. PROCEEDINGS OF THE AMERICAN PEPTIDE SYMPOSIUM, XX, XX, 1999, pages 209 - 211, XP001034997 *

Also Published As

Publication number Publication date
WO2002009649A8 (en) 2002-08-01
CA2417885A1 (en) 2002-02-07
WO2002009649A3 (en) 2002-04-11
EP1311280A2 (en) 2003-05-21
WO2002009649A2 (en) 2002-02-07
JP2004505029A (en) 2004-02-19
AU2001278113A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
HUP0301491A3 (en) Photo-labile pro-fragnance conjugates
AU3323002A (en) Erythropoietin conjugates
HUP0203652A3 (en) Gcsf conjugates
IL150153A0 (en) G-csf conjugates
AU2001240026A1 (en) Camptothecin conjugates
HUP0401265A3 (en) Improved chelator conjugates
EP1341497A4 (en) Receptor antagonist-lipid conjugates and delivery vehicles containing same
AU2001276018A1 (en) Radiolabeled immunotoxins
GB0020050D0 (en) Folder
GB0018240D0 (en) Polymeric conjugates of antitumor agents
EP1226154A4 (en) Estradiol conjugates and uses thereof
GB0119665D0 (en) Conjugates
AU2001250212A1 (en) Rhamm peptide conjugates
HK1048970A1 (en) Mechanical pencil
EP1337440A4 (en) Documents envelope
AU2001289307A1 (en) Chemically-modified myelopoietin conjugates
EP1385556A4 (en) Gastrin-receptor-avid peptide conjugates
HK1041832A1 (en) Hemoglobin-antioxidant conjugates
EP1311280A4 (en) Cell internalized peptide-drug conjugates
HK1056113A1 (en) Chemokine conjugates
GB0011818D0 (en) Lead molecule generation
AU4308001A (en) Transition metal-cyclopentadienyl-tropane conjugates
GB0012718D0 (en) Conjugates of aminodrugs
AU7426601A (en) Gene-regulating conjugates
AU2001271641A1 (en) Stable radioiodine conjugates and methods for their synthesis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030225

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050112

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050301